Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Valent

Showing results (301-310 of 316) with videos related to

Pageof 32
Sort By:
Leukemia|June 13, 2014
Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDSA Porwit, A A van de Loosdrecht, P Bettelheim, et al.
Epidemiology and Psychiatric Sciences|October 17, 2022
Prevalence of anxiety and depression in people with different types of cancer or haematologic malignancies: a cross-sectional studyE L Zeilinger, C Oppenauer, M Knefel, et al.
Leukemia|June 22, 2013
Monosomal karyotype in MDS: explaining the poor prognosis?J Schanz, H Tüchler, F Solé, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 29, 2014
Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposalP Valent, K Sotlar, W R Sperr, et al.
Leukemia|January 23, 2024
The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classificationK Nachtkamp, C Strupp, M Vukelja, et al.
Leukemia|February 5, 2015
KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on MastocytosisM Arock, K Sotlar, C Akin, et al.
European Journal of Clinical Investigation|June 1, 2007
Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteriaP Valent, C Akin, L Escribano, et al.
Leukemia|March 21, 2015
Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5qM Heuser, M Meggendorfer, M M A Cruz, et al.
Leukemia|February 1, 2012
Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): a multicenter studyU Germing, M Lauseker, B Hildebrandt, et al.
Leukemia|July 1, 2017
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosisG Martinelli, M Mancini, C De Benedittis, et al.
Pageof 32

Showing results (301-310 of 316) with videos related to

Sort By:
Pageof 32
Leukemia|June 13, 2014
Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDSA Porwit, A A van de Loosdrecht, P Bettelheim, et al.
Epidemiology and Psychiatric Sciences|October 17, 2022
Prevalence of anxiety and depression in people with different types of cancer or haematologic malignancies: a cross-sectional studyE L Zeilinger, C Oppenauer, M Knefel, et al.
Leukemia|June 22, 2013
Monosomal karyotype in MDS: explaining the poor prognosis?J Schanz, H Tüchler, F Solé, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 29, 2014
Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposalP Valent, K Sotlar, W R Sperr, et al.
Leukemia|January 23, 2024
The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classificationK Nachtkamp, C Strupp, M Vukelja, et al.
Leukemia|February 5, 2015
KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on MastocytosisM Arock, K Sotlar, C Akin, et al.
European Journal of Clinical Investigation|June 1, 2007
Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteriaP Valent, C Akin, L Escribano, et al.
Leukemia|March 21, 2015
Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5qM Heuser, M Meggendorfer, M M A Cruz, et al.
Leukemia|February 1, 2012
Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): a multicenter studyU Germing, M Lauseker, B Hildebrandt, et al.
Leukemia|July 1, 2017
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosisG Martinelli, M Mancini, C De Benedittis, et al.
Pageof 32